Susquehanna International Group, LLP Immunocore Holdings PLC Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Susquehanna International Group, LLP holds 8,894 shares of IMCR stock, worth $305,864. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,894
Previous 22,800
60.99%
Holding current value
$305,864
Previous $676,000
58.73%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMCR
# of Institutions
147Shares Held
45.1MCall Options Held
297KPut Options Held
1.17M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$243 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$167 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$145 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$130 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$84 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.51B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...